Beta-blockers in atrial fibrillation - trying to make sense of unsettling results

Markus Meyer; Daniel Lustgarten

doi:10.1093/europace/euad010

Beta-blockers in atrial fibrillation - trying to make sense of unsettling results

Markus Meyer, Daniel Lustgarten

Medicine - Cardiology Division

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Abstract

Atrial fibrillation is closely associated with heart failure and adversely affects outcomes. Beta-blockers are strongly recommended to avoid rapid ventricular conduction and tachycardia-induced cardiomyopathy. In this Viewpoint article, we discuss an emerging body of evidence that questions beta-blockers as a preferred rate-control therapy in patients with atrial fibrillation.

Original language	English (US)
Pages (from-to)	260-262
Number of pages	3
Journal	Europace
Volume	25
Issue number	2
DOIs	https://doi.org/10.1093/europace/euad010
State	Published - Feb 1 2023

Bibliographical note

Publisher Copyright:
© 2023 The Author(s). Published by Oxford University Press on behalf of the European Society of Cardiology.

Keywords

Atrial fibrillation
Beta-blockers
Diastolic dysfunction
Heart failure with preserved ejection fraction

PubMed: MeSH publication types

Journal Article

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1093/europace/euad010

Find It

Find It at U of M Libraries

Cite this

@article{7eaf9acd83e24844b4c060464bce186a,

title = "Beta-blockers in atrial fibrillation - trying to make sense of unsettling results",

abstract = "Atrial fibrillation is closely associated with heart failure and adversely affects outcomes. Beta-blockers are strongly recommended to avoid rapid ventricular conduction and tachycardia-induced cardiomyopathy. In this Viewpoint article, we discuss an emerging body of evidence that questions beta-blockers as a preferred rate-control therapy in patients with atrial fibrillation.",

keywords = "Atrial fibrillation, Beta-blockers, Diastolic dysfunction, Heart failure with preserved ejection fraction",

author = "Markus Meyer and Daniel Lustgarten",

note = "Publisher Copyright: {\textcopyright} 2023 The Author(s). Published by Oxford University Press on behalf of the European Society of Cardiology.",

year = "2023",

month = feb,

day = "1",

doi = "10.1093/europace/euad010",

language = "English (US)",

volume = "25",

pages = "260--262",

journal = "Europace",

issn = "1099-5129",

publisher = "Oxford University Press",

number = "2",

}

TY - JOUR

T1 - Beta-blockers in atrial fibrillation - trying to make sense of unsettling results

AU - Meyer, Markus

AU - Lustgarten, Daniel

PY - 2023/2/1

Y1 - 2023/2/1

N2 - Atrial fibrillation is closely associated with heart failure and adversely affects outcomes. Beta-blockers are strongly recommended to avoid rapid ventricular conduction and tachycardia-induced cardiomyopathy. In this Viewpoint article, we discuss an emerging body of evidence that questions beta-blockers as a preferred rate-control therapy in patients with atrial fibrillation.

AB - Atrial fibrillation is closely associated with heart failure and adversely affects outcomes. Beta-blockers are strongly recommended to avoid rapid ventricular conduction and tachycardia-induced cardiomyopathy. In this Viewpoint article, we discuss an emerging body of evidence that questions beta-blockers as a preferred rate-control therapy in patients with atrial fibrillation.

KW - Atrial fibrillation

KW - Beta-blockers

KW - Diastolic dysfunction

KW - Heart failure with preserved ejection fraction

UR - http://www.scopus.com/inward/record.url?scp=85148307076&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85148307076&partnerID=8YFLogxK

U2 - 10.1093/europace/euad010

DO - 10.1093/europace/euad010

M3 - Article

C2 - 36748952

AN - SCOPUS:85148307076

SN - 1099-5129

VL - 25

SP - 260

EP - 262

JO - Europace

JF - Europace

IS - 2

ER -

Beta-blockers in atrial fibrillation - trying to make sense of unsettling results

Abstract

Bibliographical note

Keywords

PubMed: MeSH publication types

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this